Recon: FDA grants priority review to Sanofi’s hemophilia A drug; Pfizer invests $500M in decentralized drug development initiative
ReconJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesBiotechnologyDiagnostics/IVDsEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy